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Abstract  
Vitamin A (retinol) is involved in signaling pathways regulating gene expression and was postulated 
to be a major antioxidant and anti-inflammatory compound of the diet. Parkinson's disease (PD) is 
a progressive neurodegenerative disorder, characterized by loss of nigral dopaminergic neurons, 
involving oxidative stress and pro-inflammatory activation. The aim of the present study was to 
evaluate the neuroprotective effects of retinol oral supplementation against 6-hydroxydopamine 
(6-OHDA, 12 μg per rat) nigrostriatal dopaminergic denervation in Wistar rats. Animals 
supplemented with retinol (retinyl palmitate, 3000 IU/kg/day) during 28 days exhibited increased 
retinol content in liver, although circulating retinol levels (serum) were unaltered. Retinol 
supplementation did not protect against the loss of dopaminergic neurons (assessed through 
tyrosine hydroxylase immunofluorescence and Western blot). Retinol supplementation prevented 
the effect of 6-OHDA on Iba-1 levels but had no effect on 6-OHDA-induced GFAP increase. 
Moreover, GFAP levels were increased by retinol supplementation alone. Rats pre-treated with 
retinol did not present oxidative damage or thiol redox modifications in liver, and the circulating 
levels of TNF-α, IL-1β, IL-6 and IL-10 were unaltered by retinol supplementation, demonstrating that 
the protocol used here did not cause systemic toxicity to animals. Our results indicate that oral 
retinol supplementation is not able to protect against 6-OHDA-induced dopaminergic denervation, 
and it may actually stimulate astrocyte reactivity without altering parameters of systemic toxicity 
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